Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ED.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CQ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.43NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.38.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19060.5South Korea
BF.7.19.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.43NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.214NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.284NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.351.3 (Beta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.318NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
R.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.29 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ML.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.283NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.96NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
L.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.192NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.39.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ME.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LE.1.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDR.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.49.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.15.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JD.1.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.441NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.509NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used